APPLICATION
ANDA077634
TYPE
ANDA
ORIGINAL APPROVAL
2006-03-17
LATEST ACTION
2022-05-25
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
ZONISAMIDEDiscontinued
ZONISAMIDE 100MG · CAPSULE · ORAL
ZONISAMIDEDiscontinued
ZONISAMIDE 25MG · CAPSULE · ORAL
ZONISAMIDEDiscontinued
ZONISAMIDE 50MG · CAPSULE · ORAL
Approval history
2022-05-25Labeling · Supplement 18 · standardAP
2016-07-18Labeling · Supplement 11 · standardAP
2015-10-07Labeling · Supplement 10 · standardAP
2015-04-24Labeling · Supplement 8 · standardAP
2010-10-26Labeling · Supplement 7AP
2010-05-31Labeling · Supplement 6AP
2010-02-26Labeling · Supplement 5AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.